B of A Securities Downgrades Amrize to Underperform, Lowers Price Target to $40

Benzinga · 3d ago
B of A Securities analyst Arnaud Lehmann downgrades Amrize (NYSE:AMRZ) from Neutral to Underperform and lowers the price target from $50 to $40.